-

-

  • Qingfu Yang Department of Pediatrics, Ganzhou Maternal and Child Health Hospital, 25 Nankang Road, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China
  • Shanshan Chen Department of Pediatrics, The Affiliated Yangming Hospital of Ningbo University(YuYao People's Hospital), No. 800 Chengdong Road, Yuyao City, Zhejiang Province, 315400, China
  • Tieniu Wu Department of Pediatrics, Ganzhou Maternal and Child Health Hospital, 25 Nankang Road, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China
  • Jingxin Peng Department of Pediatrics, Ganzhou Maternal and Child Health Hospital, 25 Nankang Road, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China
  • Lidan Mao The Affiliated Yangming Hospital of Ningbo University (YuYao People's Hospital), Department of Paediatrics, Yuyao City, Zhejiang Province, China
DOI: https://doi.org/10.5937/jomb0-57933
Ključne reči: -

Sažetak


-

Reference

1. Polidori N, Castorani V, Mohn A, Chiarelli F. Deciphering short stature in children. Ann Pediatr Endocrinol Metab. 2020;25(2):69-79.
2. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr. 2013;102(8):787-96.
3. Barstow C, Rerucha C. Evaluation of Short and Tall Stature in Children. Am Fam Physician. 2015;92(1):43-50.
4. Blum WF, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E, et al. The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 2018;7(6):R212-r22.
5. Al-Samerria S, Radovick S. The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth. Cells. 2021;10(10).
6. Wydra A, Czajka-Oraniec I, Wydra J, Zgliczyński W. The influence of growth hormone deficiency on bone health and metabolisms. Reumatologia. 2023;61(4):239-47.
7. Witkowska-Sędek E, Pyrżak B. Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis. Cent Eur J Immunol. 2020;45(4):469-75.
8. Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127-48.
9. Bernhard S, Hug S, Stratmann AEP, Erber M, Vidoni L, Knapp CL, et al. Interleukin 8 Elicits Rapid Physiological Changes in Neutrophils That Are Altered by Inflammatory Conditions. J Innate Immun. 2021;13(4):225-41.
10. Bakker AD, Jaspers RT. IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism? Curr Osteoporos Rep. 2015;13(3):131-9.
11. Savage MO, Hwa V, David A, Rosenfeld RG, Metherell LA. Genetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth. Front Endocrinol (Lausanne). 2011;2:95.
12. Chen JY, Griffiths M, Yang J, Nies MK, Damico RL, Simpson CE, et al. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension. J Pediatr. 2020;223:164-9.e1.
13. Blanchard F, Duplomb L, Baud'huin M, Brounais B. The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev. 2009;20(1):19-28.
14. Bartke A, Brown-Borg H. Mutations Affecting Mammalian Aging: GH and GHR vs IGF-1 and Insulin. Front Genet. 2021;12:667355.
15. Cirillo F, Lazzeroni P, Sartori C, Street ME. Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate. Int J Mol Sci. 2017;18(9).
16. DeBoer MD, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, et al. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition. 2017;33:248-53.
17. Hwa V, Fujimoto M, Zhu G, Gao W, Foley C, Kumbaji M, et al. Genetic causes of growth hormone insensitivity beyond GHR. Rev Endocr Metab Disord. 2021;22(1):43-58.
Objavljeno
2025/07/02
Broj časopisa
Vol. 44 Br. 8 (2025): Journal of Medical Biochemistry
Rubrika
Original paper

Sva prava zadržana (c) 2025 Lidan Mao

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.